104 related articles for article (PubMed ID: 6396113)
1. Reduction of the in vivo virulence of Candida albicans by pretreatment with subinhibitory azole concentrations in vitro.
Plempel M; Berg D
Dermatologica; 1984; 169 Suppl 1():11-8. PubMed ID: 6396113
[TBL] [Abstract][Full Text] [Related]
2. Candida albicans adhesion to and invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole.
Wächtler B; Wilson D; Hube B
Antimicrob Agents Chemother; 2011 Sep; 55(9):4436-9. PubMed ID: 21746947
[TBL] [Abstract][Full Text] [Related]
3. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
[TBL] [Abstract][Full Text] [Related]
4. Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.
Odds FC; Webster CE
J Antimicrob Chemother; 1988 Oct; 22(4):473-81. PubMed ID: 2849601
[TBL] [Abstract][Full Text] [Related]
5. Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole.
Berg D; Regel E; Harenberg HE; Plempel M
Arzneimittelforschung; 1984; 34(2):139-46. PubMed ID: 6372801
[TBL] [Abstract][Full Text] [Related]
6. Germ tube-forming cells of Candida albicans are more susceptible to clotrimazole-induced killing than yeast cells.
Niimi M; Kamiyama A; Tokunaga M; Tokunaga J; Nakayama H
Sabouraudia; 1985 Feb; 23(1):63-8. PubMed ID: 3887603
[TBL] [Abstract][Full Text] [Related]
7. The action of miconazole of the growth of Candida albicans.
Van Den Bossche H; Willemsens G; Van Cutsem JM
Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
[TBL] [Abstract][Full Text] [Related]
8. The influence of subinhibitory concentrations of conventional and experimental antifungal drugs on the expression of the iC3b binding protein in Candida albicans strains during filamentation.
Bujdáková H; Lell CP; Gruber A; Langgartner M; Spötl L; Kurisková S; Klobusický M; Dierich MP; Würzner R
FEMS Immunol Med Microbiol; 1999 Oct; 26(1):1-10. PubMed ID: 10518038
[TBL] [Abstract][Full Text] [Related]
9. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Odds FC; Cockayne A; Hayward J; Abbott AB
J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
[TBL] [Abstract][Full Text] [Related]
10. Mode of action of clotrimazole: implications for therapy.
Haller I
Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 2):939-44. PubMed ID: 3895959
[TBL] [Abstract][Full Text] [Related]
11. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds.
Wakabayashi H; Okutomi T; Abe S; Hayasawa H; Tomita M; Yamaguchi H
Adv Exp Med Biol; 1998; 443():229-37. PubMed ID: 9781363
[TBL] [Abstract][Full Text] [Related]
12. [Effect of synthetic antifungal drugs on the adherence of Candida albicans to the mouth mucosa epithelium in vitro].
Macura AB; Dwernicka B
Med Dosw Mikrobiol; 1989; 41(1):67-70. PubMed ID: 2668662
[TBL] [Abstract][Full Text] [Related]
13. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans.
Pfaller MA; Riley J; Koerner T
Diagn Microbiol Infect Dis; 1990; 13(1):31-5. PubMed ID: 2184984
[TBL] [Abstract][Full Text] [Related]
14. 5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans.
Subramenium GA; Swetha TK; Iyer PM; Balamurugan K; Pandian SK
Microbiol Res; 2018 Mar; 207():19-32. PubMed ID: 29458854
[TBL] [Abstract][Full Text] [Related]
15. Bifonazole, a biochemist's view.
Berg D; Plempel M
Dermatologica; 1984; 169 Suppl 1():3-9. PubMed ID: 6396116
[TBL] [Abstract][Full Text] [Related]
16. [The mode of action of imidazole antimycotics: implications for sensitivity testing (author's transl)].
Haller I
Mykosen; 1979 Dec; 22(12):423-30. PubMed ID: 396473
[No Abstract] [Full Text] [Related]
17. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents.
Wakabayashi H; Abe S; Okutomi T; Tansho S; Kawase K; Yamaguchi H
Microbiol Immunol; 1996; 40(11):821-5. PubMed ID: 8985937
[TBL] [Abstract][Full Text] [Related]
18. [Cytological study of the action of imidazoles on Candida albicans (author's transl)].
Bastide M; Jouvert S; Bastide JM
Pathol Biol (Paris); 1982 Jun; 30(6):458-62. PubMed ID: 7050853
[TBL] [Abstract][Full Text] [Related]
19. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
Navarathna DH; Hornby JM; Hoerrmann N; Parkhurst AM; Duhamel GE; Nickerson KW
J Antimicrob Chemother; 2005 Dec; 56(6):1156-9. PubMed ID: 16239285
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agents.
Pfaller MA; Gerarden T
Diagn Microbiol Infect Dis; 1989; 12(6):467-71. PubMed ID: 2696620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
